Clinical Trials Logo

Intractable Cancer Pain clinical trials

View clinical trials related to Intractable Cancer Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03226574 Completed - Clinical trials for Intractable Cancer Pain

Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain

Start date: September 1, 2017
Phase: Phase 1
Study type: Interventional

The study is a multicenter, open-label Phase 1b single dose escalation safety study for adult subjects with intractable pain associated with cancer in any area below the mid-thoracic level who meet all other eligibility criteria.